AA → COX/LOX
With greater predominance of arachidonic acid (AA), there is more substrate for mediators such as PGE2, LTB4 and TXA2 and for activation of pathways such as NF-κB.
html
When the omega-6:3 ratio is high and the Omega-3 Index is low, there is greater arachidonic-acid pressure on pro-inflammatory pathways and less EPA+DHA available for membranes and resolution mediators.
This profile is strongly consistent with a pro-inflammatory environment, so correcting it means aiming for less relative AA predominance, more EPA+DHA in membranes and greater capacity to produce mediators that help resolve the inflammatory response.
With greater predominance of arachidonic acid (AA), there is more substrate for mediators such as PGE2, LTB4 and TXA2 and for activation of pathways such as NF-κB.
EPA and DHA enter membranes and give rise to pro-resolving mediators, including resolvins, protectins and maresins. A low status reduces this availability.
When activation is prolonged, markers and cytokines such as CRP, IL-6 and TNF-α can remain elevated and the process begins to affect multiple systems.
It favours endothelial dysfunction, atherosclerosis and a more reactive vascular environment.
It is involved in insulin resistance, visceral adiposity, metabolic syndrome and fatty liver.
Persistent neuroinflammation is linked to cognitive decline and mechanisms of neurodegenerative disease.
Persistent cytokine activity and inflammatory signalling alter the balance of the immune response and are present in several inflammatory and autoimmune diseases.
A greater inflammatory burden can prolong discomfort, damage and recovery after intense exertion.
So-called inflammaging links persistent inflammation to frailty, functional loss and greater risk of chronic disease with age.
| Indicator | When unfavourable | Objective |
|---|---|---|
| Omega-6:3 ratio | AA highly dominant relative to EPA | ≈ 3:1 or below |
| Omega-3 Index | Low EPA+DHA incorporation | ≥ 8% |
EPA competes with AA for the same enzyme families, while DHA/EPA enrich cell membranes. At the same time, EPA and DHA are precursors of specialised pro-resolving mediators. This combination — less relative AA predominance and more available EPA+DHA — makes correcting the profile biologically relevant and helps reduce pro-inflammatory pressure while favouring resolution of the inflammatory response.
View the complete scientific library →
Chronic low-grade inflammation acts as a bridge between the fatty-acid profile and different systems. See how the same mechanism appears in heart and blood vessels, metabolism and liver, brain, skin, joints and longevity.
Yes. The process can remain silent for long periods while still maintaining active inflammatory signalling.
Because the ratio shows the relative predominance of AA over EPA, while the Omega-3 Index shows EPA+DHA incorporation. Together they provide a more complete picture of the lipid environment.
Bring the ratio close to 3:1 or below and raise the Omega-3 Index to 8% or more, confirming the change with a retest.
Continue from the article to reviewed presentations and return to the topic pages whenever you want to examine the evidence in more depth.